%20(1).jpg)

Latest Articles
%20(1).jpg)

How to Start and Switch Insulin: an HCP's guide
A practical guide for initiating or switching patients to a new insulin

Efficacy & Safety Profile
Beyfortus®▼ (nirsevimab)

The BRIGHT Study: Comparing Toujeo® (insulin glargine 300 U/mL) and Insulin Degludec 100 U/mL
Efficacy and safety considerations are essential for effective Type 2 diabetes management.

Pompe Disease Awareness
A short video raising awareness of Pompe disease

Praluent® (alirocumab) Administration
.jpg)
Get in Touch

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment
Read to learn more about what tools can help you identify your patients with uncontrolled AD

About Beyfortus®▼ (Nirsevimab): Clinical Efficacy, Real-World Impact, and Duration of Protection
Beyfortus®▼ (Nirsevimab)
MAT-XU-2305061 (v2.0) Date of preparation: February 2024